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Abstract 
The clinical significance of Xp22.31 microduplication is still unclear. We describe a family in 
which mother and two children have Xp22.31 microduplication associated with different forms of 
epilepsy and epileptiform EEG abnormalities. The proband had benign epilepsy with 
centrotemporal spikes with dysgraphia and dyscalculia (IQ 72), the sister had juvenile myoclonic 
epilepsy, and both had bilateral talipes anomalies. The mother, carrier of the microduplication, was 
asymptomatic. The asymptomatic father did not present microduplication. These data contribute to 
delineate the phenotype associated with Xp22.31 microduplication and suggest its pathogenic role, 
probably additive, also for the epilepsy phenotype. 
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Abbreviations 
Benign epilepsy with centrotemporal spikes (BECTS); SNP-array, single nucleotide polymorphism 
microarray; ILS.  intermittent light stimulation; PS, pattern stimulation. 
 
Key Words: Epilepsy, EEG abnormalities, Xp22.31 microduplication, phenotype 
 
1. Introduction 
Xp22.31 microduplication is one of the most frequent findings in clinical cytogenetic analysis [1, 
2]. The frequency varies according to the criteria of sample selection, ranging from 0.04% in 
multicenter studies based on noninvasive prenatal testing [3], and 2.4% in patients with mental 
retardation [4]. In patients with epilepsy, Olson et al. [5] found at least one copy number variant on 
chromosomal microarray in 323 out of 805 studied cases (40%), and 30 of these (9.3%) had 
Xp22.31 microduplication. Recently, Addis et al. [6] found this duplication in 2.2% of patients with 
benign epilepsy with centrotemporal spikes (BECTS). Even if the clinical significance of the 
rearrangement is still debated, the most recent studies confirm its possible pathogenic role, although 
probably not alone but linked to additive genetic factors [7]. The phenotype is variable with 
prevalence of neurocognitive and behavioral disorders, but seizures are however reported in 3-44% 
of cases [2,  5-8]. Dysmorphic features, talipes anomalies, and feeding difficulties may also occur 
[5-8]. Severity and intensity of the phenotypes are variable; intellectual disability range from mild 
to severe mental retardation, in some patients associated with autism spectrum disorder, speech and 
reading difficulty, dyslexia, and attention deficit hyperactivity disorder. Also the epilepsy 
phenotype varies from neonatal seizures to BECTS, Dravet-like onset epilepsy, and refractory 
myoclonic epilepsy [2-8]. In the present study we analyzed four members of a family in which two 
children present Xp22.31 microduplication associated with different forms of epilepsy. 
2. Material and methods 
We studied a nuclear family of four members (non-consanguine parents and two children). 
Underwritten informed consent, all members underwent clinical, EEG, neuro-imaging and 
laboratory evaluations based on specific clinical indications for each subject. Video-EEG 
monitoring was recorded in each member at rest and during standardized visual stimuli with 
intermittent light stimulation (ILS), pattern stimulation (PS) and watching television, according to a 
protocol used in our centre [9]. Genomic DNA of each member was extracted from peripheral 
blood with standard procedures and analyzed by single nucleotide polymorphism microarray-based 
analysis (SNP-array Cytoscan; Affymetrix, Santa Clara, CA). 
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3. Results 
The family pedigree is shown in Fig. 1. 
3.1. Proband 
Six-year-old boy (IV 27, Fig.1), born at term from normal pregnancy. Normal growth in height, 
weight and psychomotor development. At 5.7 years of age he started to have focal seizures on 
awakening with sensorimotor symptoms with tonic contraction of one side of the face, 
oropharyngeal automatisms, sialorrhea, and speech arrest. At school he needed educational support 
because of learning difficulties, dysgraphia, and dyscalculia. His total intellectual level (WAIS-IV 
test) was 72 (verbal 73, performance 77). General physical examination showed bilateral talo-
valgus, described by parents more prominent in the first months of life. Neurological examination 
was normal. Waking video-EEG showed rare spikes and sharp waves in centro-occipital regions 
without changes during ILS, PS and TV. Sleep video-EEG showed bihemispheric independent 
centrotemporal spikes/sharp waves suggesting BECTS (Figure 2 A). Brain NMR was normal. 
Therapy was started with valproic acid up to 600 mg/day with complete seizure control (last 
episode at the age of 7.6 years). At the end of the follow-up (age 18.11 years) he was in remission 
for about 10 years, with normalized EEG at the age of 13.4 years, and AED therapy suspended for 
over five years. 
3.2. Sister 
Thirteen-year-old girl (IV 26, Fig. 1) born at term from normal pregnancy. Normal growth in 
height, weight and psychomotor development. No learning difficulties. She came to examination at 
the age of 14 years for myoclonic jerks in the upper limbs started five months before. Myoclonic 
jerks predominantly occurred after awakening, with abrupt fall of objects, and rare drop attacks. 
Some episodes were triggered by visual environmental stimuli, particularly watching TV. Two 
months after the myoclonic onset, she had a generalized tonic-clonic seizure during wake. General 
physical examination showed bilateral talo-valgus. Neurological examination was normal. Her total 
intellectual level (WAIS-IV test) was 95 (verbal 86, performance 108). Wake video-EEG recording 
showed generalized epileptiform EEG abnormalities with or without concomitant myoclonic jerks 
at rest (Fig. 2 B), activated by ILS (Fig. 2 C) and PS. During watching television, she had five 
seizures characterized by peri-oral or head myoclonia, and an episode of abrupt rhythmic 
nystagmoid eye movements. The patient's clinical and EEG features were in accordance with the 
diagnostic criteria for juvenile myoclonic epilepsy (JME) [10]. Lamotrigine therapy was started up, 
but with poor seizure control, whereby it was gradually replaced with valproic acid up to 600 
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mg/day with complete seizure remission (normalized EEG at the age of 19.8 years) which still 
persisted at the end of follow-up (age of 22 years). 
3.3. Mother 
Fifty-two-year-old woman (III 28, Fig. 1) with unremarkable clinical history (no seizures). General 
and neurological examinations were normal. The video-EEG did not show any abnormalities. Brain 
NMR showed millimetric areas of gliosis due to previous involvement of the cerebral 
microcirculation. 
3.4. Father 
Sixty-three-year-old man (III 27, Fig. 1) with unremarkable clinical history (no seizures). General 
and neurological examinations were normal. The video-EEG did not show any abnormalities. Brain 
NMR showed millimetric areas of gliosis due to previous involvement of the cerebral 
microcirculation. 
3.5. SNP-array analysis 
The analysis detected  a microduplication of about 1.7 Mb at Xp22.31, extending from 6,449,233 to 
8,135,644 bp (hg19 genomic release) in the two sons and their mother. No SNP-array alterations 
were found in the father. 
4. Discussion 
In literature there are no concordant data on the pathogenicity of Xp22.31 microduplication, which 
has been interpreted in some cases as a variant with an unspecified meaning [1, 4] or benign [11, 
12], in others as a cause of developmental disorders, including autism, intellectual disability, 
hypotonia and eating disorders [2, 7, 13]. Cognitive level and learning difficulties of our proband 
confirm the pathogenic role of Xp22.31 microduplication with respect to cognitive disabilities. 
Regarding the epilepsy phenotype, previous studies reported seizures in 3-17% of cases [2, 5, 7] 
and epileptiform EEG abnormalities in 25% [7]. Recently, Esplin et at.
 
[8] described nine patients 
with this type of mutation, inherited from the mother in all subjects, in which the most frequent 
phenotypic anomalies were cognitive disability (67%), epilepsy (44% ) and talipes anomalies 
(33%). Epilepsy syndromes are rarely reported in patients with copy number variations at Xp22.31; 
among 10 cases studied by Olson et al. [5]
 
only 3 had electro-clinical features fitting with defined 
epilepsy syndromes (neonatal seizures, BECTS, Dravet-like onset epilepsy). In the present study, 
three members had Xp22.31 microduplication, and two of them had epileptiform EEG anomalies 
associated with idiopathic epilepsy, with different age-dependent syndromes (BECTS in the 
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proband, JME in the sister). These data support the hypothesis that Xp22.31 microduplication may 
have a pathogenetic role in the expression of epilepsy phenotype, probably by an additive effect, as 
suggested by Liu et al. [7].
  
BECTS and JME have a complex inheritance, probably linked to the interaction of different genes, 
as other common forms of  idiopathic epilepsies [14]. In BECTS, the segregation analysis of the 
‘EEG trait’ (centrotemporal spike/sharp waves) fit with a highly penetrant autosomal dominant 
model of inheritance, with strong evidence of a single genomewide locus at 11p13 [15-17]. The 
segregation analysis of JME excluded simple Mendelian modes of inheritance, while supported a 
model involving two genes, one dominant and one recessive [17, 18]. Linkage analyses, genome-
wide association studies, and fine-mapping resulted in the identification of susceptibility genes 
ELP4 in BECTS (Pal and Greenberg, 2012). Five mendelian genes have been identified in JME 
(CACNB4, CASR, GABRa1, GABRD, Myoclonin1/EFHC1) [19]. Three SNP alleles (in BRD2, 
Cx-36, ME2) and some microdeletions (in 15q13.3, 15q11.2, and 16p13.11) also contribute risk to 
JME [17, 19]. The Xp22.31 microduplication may act in a close relationship with both specific 
epilepsy genes and cerebral maturation processes. Moreover, the phenotypic variability may be 
related to other modifiers in the genomic background as reduced penetrance, different genes in the 
region of duplication, and position effect [8, 20, 21]. Besides, X inactivation could also play a 
significant role in the expression of this duplication [8, 22]; in fact, both children of the present 
family had maternal inherited Xp22.31 duplication, but their mother was asymptomatic. 
5. Conclusions 
The family we studied provides a contribution to define a common phenotype related with Xp22.31 
duplication, with special attention to the epilepsy, and underlines the need to further studies on 
mechanisms that influence its expressivity. 
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Fig. 1. Pedigree of the family 
 
Fig. 2.    A. Proband. Sleep EEG: bihemispheric independent centrotemporal spikes/sharp waves. 
B. Sister. Wake EEG: diffuse burst of spikes, polyspikes, spike-wave and polyspike wave 
complexes at 3-4 Hz of high voltage. C. Sister. Generalized polyspikes induced by ILS (EC = eyes 
closed). (Marker amplitude in A and B = 150 μV; in C and D = 100 μV) 
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Highlights: 
 
 Developmental disorders are commonly associated with Xp22.31 microduplication. 
 
 Seizures may occur but specific epileptic syndromes are rare. 
 
 Xp22.31 microduplication may have an additive role in epilepsy phenotype expression. 
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